The activation of the mTOR (mechanistic target of rapamycin) pathway seems to regulate autophagy in cancer cells through the complex mTORC1, and CUR deactivates this regulation by deactivation of the PI3K (Phosphoinositide 3-kinase)/Akt/mTOR pathway, extensively demonstrated in multiple cell culture models [31]. The gene discussed is MTOR; the disease is cancer.